NASOPHARYNGITIS

This adverse event was reported 184514 times

These drugs are most commonly taken by patients reporting NASOPHARYNGITIS:

# Drug Count
See all common drugs associated with NASOPHARYNGITIS

NASOPHARYNGITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
See all drugs enriched for association with NASOPHARYNGITIS

NASOPHARYNGITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 2304 3.3488
1 Provitamin D2 Compound [EPC] 10059 0.3380
2 Interleukin-17A Antagonist [EPC] 8544 0.2292
3 Endoglycosidase [EPC] 330 0.1781
4 PCSK9 Inhibitor [EPC] 3109 0.1207
5 Guanylate Cyclase-C Agonist [EPC] 220 0.1060
6 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 878 0.1007
7 Human Immunoglobulin G [EPC] 2103 0.0999
8 Adrenocorticotropic Hormone [EPC] 84 0.0939
9 Integrin Receptor Antagonist [EPC] 7035 0.0808
See all drug classes enriched for association with NASOPHARYNGITIS